REFRACTORY BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
Clinical trials for REFRACTORY BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM trials appear
Sign up with your email to follow new studies for REFRACTORY BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug Q702 aims to boost immune system against blood cancers
Disease control Recruiting nowThis early-phase trial is testing a new drug called Q702 in about 46 people with various blood cancers or histiocytic disorders (diseases where certain immune cells grow out of control). Q702 is designed to help the immune system kill cancer cells and help the bone marrow make no…
Matched conditions: REFRACTORY BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 23, 2026 11:59 UTC
-
Engineered immune cells take aim at returning leukemia
Disease control Recruiting nowThis early-phase trial tests a new type of immunotherapy for children and adults whose acute leukemia has come back or not responded after a donor stem cell transplant. The treatment uses specially engineered donor immune cells (T cells) that are designed to recognize and attack …
Matched conditions: REFRACTORY BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 22, 2026 11:57 UTC